Inaugural list of price controls on U.S. medicines means hard choices for investors


October 26, 2023

by John Stanford

The Centers for Medicare & Medicaid Services recently announced the first 10 drugs that will be subject to Medicare’s new price controls. More drugs will follow each year.

Industry is grappling with the effects this change will have on new drug development -- and it’s clear t...

For access to this article please sign in or subscribe.


Reader Comments(0)


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2023

Rendered 11/29/2023 22:58